rs772492538

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_001365536.1(SCN9A):​c.2166G>C​(p.Leu722Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000308 in 1,592,374 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L722S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000031 ( 0 hom. )

Consequence

SCN9A
NM_001365536.1 missense

Scores

7
9
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 0.301

Publications

4 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN9ANM_001365536.1 linkc.2166G>C p.Leu722Phe missense_variant Exon 14 of 27 ENST00000642356.2 NP_001352465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN9AENST00000642356.2 linkc.2166G>C p.Leu722Phe missense_variant Exon 14 of 27 NM_001365536.1 ENSP00000495601.1 Q15858-1
SCN9AENST00000303354.11 linkc.2166G>C p.Leu722Phe missense_variant Exon 14 of 27 5 ENSP00000304748.7 Q15858-1
SCN9AENST00000409672.5 linkc.2133G>C p.Leu711Phe missense_variant Exon 14 of 27 5 ENSP00000386306.1 Q15858-3
SCN9AENST00000645907.1 linkc.2133G>C p.Leu711Phe missense_variant Exon 14 of 27 ENSP00000495983.1 Q15858-4
SCN9AENST00000454569.6 linkc.2133G>C p.Leu711Phe missense_variant Exon 14 of 15 1 ENSP00000413212.2 A0A0C4DG82

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152114
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.0000184
AC:
4
AN:
217000
AF XY:
0.0000343
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000216
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000106
Gnomad OTH exome
AF:
0.000184
GnomAD4 exome
AF:
0.0000312
AC:
45
AN:
1440142
Hom.:
0
Cov.:
31
AF XY:
0.0000322
AC XY:
23
AN XY:
713994
show subpopulations
African (AFR)
AF:
0.0000602
AC:
2
AN:
33208
American (AMR)
AF:
0.00
AC:
0
AN:
42164
Ashkenazi Jewish (ASJ)
AF:
0.000196
AC:
5
AN:
25558
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83098
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52098
Middle Eastern (MID)
AF:
0.00209
AC:
12
AN:
5734
European-Non Finnish (NFE)
AF:
0.0000191
AC:
21
AN:
1099544
Other (OTH)
AF:
0.0000840
AC:
5
AN:
59546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152232
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41544
American (AMR)
AF:
0.0000654
AC:
1
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68000
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000901
Hom.:
0
ExAC
AF:
0.0000333
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Nov 01, 2020
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 19, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Observed in patients with epilepsy; however, further clinical information was not provided (Hussein et al., 2023); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: Hussein2023[medRxiv]) -

Inborn genetic diseases Uncertain:1
Sep 22, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.L711F variant (also known as c.2133G>C), located in coding exon 13 of the SCN9A gene, results from a G to C substitution at nucleotide position 2133. The leucine at codon 711 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Uncertain:1
Oct 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 711 of the SCN9A protein (p.Leu711Phe). This variant is present in population databases (rs772492538, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SCN9A-related conditions. ClinVar contains an entry for this variant (Variation ID: 575125). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SCN9A protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Pathogenic
0.35
D
BayesDel_noAF
Pathogenic
0.30
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.59
.;D;.;.;D;.;.
Eigen
Uncertain
0.32
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.89
D;.;D;D;D;D;D
M_CAP
Pathogenic
0.53
D
MetaRNN
Uncertain
0.72
D;D;D;D;D;D;D
MetaSVM
Pathogenic
0.96
D
MutationAssessor
Pathogenic
3.6
.;H;.;.;H;H;.
PhyloP100
0.30
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-3.8
D;.;.;.;.;D;.
REVEL
Pathogenic
0.84
Sift
Pathogenic
0.0
D;.;.;.;.;D;.
Sift4G
Benign
0.078
T;T;.;.;.;T;.
Vest4
0.67
MutPred
0.44
Loss of catalytic residue at L711 (P = 0.0053);.;Loss of catalytic residue at L711 (P = 0.0053);Loss of catalytic residue at L711 (P = 0.0053);.;.;Loss of catalytic residue at L711 (P = 0.0053);
MVP
0.83
MPC
0.58
ClinPred
0.99
D
GERP RS
3.0
Varity_R
0.65
gMVP
0.21
Mutation Taster
=8/92
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs772492538; hg19: chr2-167137044; API